natgillin/translations-raw huggingface dataset:
R10, at each occurrence, is independently selected from alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl, wherein the cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl may each be optionally substituted with 0-3 R10a; 
, svaki put kada je prisutan, je nezavisno izabran između alkil, alkenil, alkinil, cikloalkil, aril, arilalkil, heteroaril, heteroarilalkil, heterociklil i heterociklilalkil, gdje cikloalkil, aril, arilalkil, heteroaril, heteroarilalkil, heterociklil i heterociklilalkil može svaki biti po izboru supstituiran s 0-3 R10a;
R10, at each occurrence, is independently selected from alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl, wherein the cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl may each be optionally substituted with 0-3 R10; 
, svaki put kada je prisutan, je nezavisno izabran između alkil, alkenil, alkinil, cikloalkil, aril, arilalkil, heteroaril, heteroarilalkil, heterociklil i heterociklilalkil, gdje cikloalkil, aril, arilalkil, heteroaril, heteroarilalkil, heterociklil i heterociklilalkil može svaki biti po izboru supstituiran s 0-3 R10;
A compound according to Claim 1 selected from the group consisting of: 
Spoj prema zahtjevu 1 izabran iz grupe koja obuhvaća:
A compound of any one of claims 1 to 12 for use in a method for preventing, inhibiting, or treating the progression or onset of diseases or disorders associated with the activity of the GPR 119 G protein-coupled receptor and, optionally, further using an additional therapeutic agent wherein: 
Spoj prema bilo kojem od zahtjeva 1 do 12 za uporabu u postupku prevencije, inhibicije ili liječenja napredovanja ili početka bolesti ili poremećaja koji su povezani s aktivnošću GPR protein-vezanog receptora i, po izboru, daljnja uporaba dodatne djelatne tvari gdje:
the diseases or disorders are selected from the group consisting of diabetes, hyperglycemia, impaired glucose tolerance, insulin resistance, hyperinsulinemia, retinopathy, neuropathy, nephropathy, delayed wound healing, atherosclerosis and its sequelae, abnormal heart function, myocardial ischemia, stroke, Metabolic Syndrome, hypertension, obesity, dislipidemia, dyslipidemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL, high LDL, non-cardiac ischemia, infection, cancer, vascular restenosis, pancreatitis, neurodegenerative disease, lipid disorders, cognitive impairment and dementia, bone disease, HIV protease associated lipodystrophy and glaucoma; and 
bolesti ili poremećaji se izabiru iz grupe koja obuhvaća dijabetes, hiperglikemiju, poremećaj tolerancije glukoze, rezistenciju na inzulin, hiperinzulinemiju, retinopatiju, neuropatiju, nefropatiju, produljeno zarastanje rana, aterosklerozu i njezin nastavak, abnormalnu srčanu funkciju, ishemiju miokarda, moždani udar, metabolički sindrom, hipertenziju, pretilost, dislipidemiju, dislipidemiju, hiperlipidemju, hipertrigliceridemiju, hiperkolesterolemiju, nizak HDL, visoki LDL, ne-srčanu ishemiju, infekciju, rak, vaskularnu restenozu, pankreatitis, neurodegenerativnu bolest, lipidne poremećaje, poremećaj kognitivne funkcije i demenciju, bolesti kostiju, lipodistrofiju povezanu s proteazom HIV-a i glaukom; i
A pharmaceutical composition comprising a therapeutically effective amount of a compound of any one of Claims 1 to 12 and a therapeutically effective amount of a dipeptidyl peptidase-IV (DPP4) inhibitor. 
Farmaceutska smjesa koja sadrži terapijski učinkovitu količinu spoja prema bilo kojem od zahtjeva 1 do 12 i terapijski učinkovitu količinu inhibitora dipeptidil peptidaze-IV (DPP4).
The fibers according to claim 1, containing 0.01 mg or more of said nano-sized diamond and 0.0001 mg or more of said platinum nanocolloid per 1 kg of said fibers. 
Vlakna u skladu s patentnim zahtjevom 1, naznačena time što sadrže 0,01 mg ili više navedenog dijamanta nano-veličine i 0,0001 mg ili više navedenog platinskog nanokoloida po 1 kg navedenih vlakana.
The fibers according to claim 1 or 2, containing 3 mg or more of said nano-sized diamond and 0.03 mg or more of said platinum nanocolloid per 1 kg of said fibers. 
Vlakna u skladu s patentnim zahtjevom 1 ili 2, naznačena time što sadrže 3 mg ili više navedenog dijamanta nano-veličine i 0,03 mg ili više navedenog platinskog nanokoloida po 1 kg navedenih vlakana.
The fibers according to any one of claims 1-4, containing 0.1 g or less of said nano-sized diamond and 1 mg or less of said platinum nanocolloid per 1 kg of said fibers. 
Vlakna u skladu s bilo kojim od patentnih zahtjeva 1-4, naznačena time što sadrže 0,1 g ili manje navedenog dijamanta nano-veličine i 1 mg ili manje navedenog platinskog nanokoloida po 1 kg navedenih vlakana.
The fibers according to any one of claims 1-5, wherein the platinum nanocolloid content is 1/1000 to 1/1 of the nano-sized diamond content. 
Vlakna u skladu s bilo kojim od patentnih zahtjeva 1-5, naznačena time što platinski sadržaj nanokoloida je 1/1000 do 1/1 sadržaja dijamanta nano-veličine.
Process for the preparation of a treated mineral filler product, characterised in that said process comprises the following steps: 
Postupak za pripremu obrađenih mineralnih punila, naznačen time da se navedeni postupak sastoji od sljedećih koraka:
providing at least one dry mineral filler; 
pripreme najmanje jednog suhog mineralnog punila;
contacting said mineral filler(s) of step (a), in one or more steps under heating, with: 
kontakta navedenog(ih) mineralnog(ih) punila iz koraka (a), u jednom ili više koraka uz grijanje, sa:
a treatment layer comprising said aliphatic carboxylic acid(s) and said aliphatic carboxylic acid salt(s) is formed on the surface of said mineral filler(s) resulting in a treated mineral filler product; 
stvaranja na površini navedenog(ih) mineralnog(ih) punila obrađenog sloja koji sadrži navedenu alifatsku karboksilnu kiselinu odnosno alifatske karboksilne kiseline i navedenu sol alifatske karboksilne kiseline odnosno soli alifatskih karboksilnih kiselina, što dovodi do obrađenog mineralnog punila kao produkta;
the total weight of all of said aliphatic carboxylic acid salt(s) and all of said aliphatic carboxylic acid(s) located on the surface of the mineral filler is at least 2.5 mg/m2 of the mineral filler provided in step (a); 
ukupna težina svih navedenih soli alifatskih karboksilnih kiselina i svih navedenih alifatskih karboksilnih kiselina koje se nalaze na površini mineralnog punila je barem 2.5 mg/m mineralnog punila pripremljenog u koraku (a);
during step (d), the temperature is adjusted such that all of the aliphatic carboxylic acid(s) and aliphatic carboxylic acid salt(s) are molten. 
tijekom koraka (d), temperatura je podešena tako da su rastaljene sve alifatske karboksilne kiseline i sve soli alifatskih karboksilnih kiselina.
Process according to any of claims 1 to 12, characterised in that the C8 to C24 aliphatic carboxylic acid(s) are fatty acid(s), especially stearic and/or palmitic and/or myristic and/or lauric acids or mixtures thereof, and most preferably are stearic and/or palmitic acid. 
Postupak prema bilo kojem od zahtjeva 1 do 12, naznačen time da C8 do C24 alifatska karboksilna kiselina odnosno alifatske karboksilne kiseline su masne kiseline, posebice stearinska i/ili palmitinska i/ili miristinska i/ili laurinska kiselina ili njihove mješavine, te su najpoželjnije stearinska i/ili palmitinska kiselina.
Process according to any of claims 1 to 13, characterised in that the total aliphatic carboxylic acid(s) and aliphatic carboxylic acid salt(s) accounts for greater greater than 2.7, more preferably at least 3, especially at least 3.2, e.g. 
Postupak prema bilo kojem od zahtjeva 1 do 13, naznačen time da je ukupna količina alifatske karboksilne kiseline (alifatskih karboksilnih kiselina) i soli alifatske karboksilne kiseline veća od 2.7, još poželjnije barem 3, odnosno barem 3.2, npr.
3.5 mg of total aliphatic carboxylic acid(s) and aliphatic carboxylic acid salt(s)/m2 of mineral filler(s). 
3.5 mg ukupne količine alifatske karboksilne kiseline (alifatskih karboksilnih kiselina) i soli alifatske karboksilne kiseline/m mineralnog odnosno mineralnih punila.
Process according to any of claims 1 to 15, characterised in that the aliphatic carboxylic acid is a 1:1 stearic acid:palmitic acid mixture, and the aliphatic carboxylic acid salt(s) is a magnesium or calcium stearate. 
Postupak prema bilo kojem od zahtjeva 1 do 15, naznačen time da je alifatska karboksilna kiselina mješavina u omjeru 1:1 stearinske kiseline i palmitinske kiseline, a soli alifatske karboksilne kiseline su magnezij ili kalcij stearat.
Process according to any of claims 1 to 17, characterised in that the aliphatic carboxylic acid salt(s) provided to step (c) are in a molten state. 
Postupak prema bilo kojem od zahtjeva 1 do 17, naznačen time da su soli alifatske karboksilne kiseline (alifatskih karboksilnih kiselina) pripremljene u koraku (c) u rastaljenom stanju.
Use of a product according to any of claims 1 to 20 or 40 to 43 in a process of mixing and/or extruding and/or compounding and/or blow moulding with plastic materials. 
Uporaba produkta dobivenog pomoću postupka prema bilo kojem od zahtjeva 1 do 19 naznačena time da je za postupak miješanja i/ili ekstruzije i/ili kombiniranja i/ili injekcijskog prešanja plastičnih materijala.
The films according to claim 22, characterised in that they are selected from the group comprising stretched and/or oriented films, and preferably breathable films, or extrusion coating films. 
Filmovi prema zahtjevu 22, naznačeni time da su odabrani iz skupine koja sadrži razvučene i/ili orijentirane filmove, te poželjno prozračne filmove, ili filmove ekstruzijskih prevlaka.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) mandipropamid. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) mandipropamid. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition suitable for control of diseases caused by phytopathogens comprising (A) a compound of formula I wherein R1 is difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) the compound cyprodinil. 
Pripravak koja je pogodan za kontrolu bolesti koje uzrokuju fitopatogeni, naznačen time što sadrži (A) spoj formule (I) [image] pri čemu je R1 difluorometil ili trifluorometil i X je kloro, fluoro ili bromo; te
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) cyprodinil. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) cyprodinil. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) fludioxonil. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) fludioxonil. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) chlorothalonil. 
Spoj prema zahtjevu 1, naznačen time, da sadrži kao komponentu (A) spoj (9-diklorometiliden-benzonorbornen-5-il)amid 3-difluorometil-1-metil-1H-pirazol-4-karboksilne kiseline, te kao komponentu (B) fenpropidin.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) chlorothalonil. 
Spoj prema zahtjevu 1, naznačen time, da sadrži kao komponentu (A) spoj (9-difluorometiliden-benzonorbornen-5-il)amid 3-difluorometil-1-metil-1H-pirazol-4-karboksilne kiseline, te kao komponentu (B) fenpropidin.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) fluopyram. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) fenpropimorf.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) fluopyram. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) fenpropimorf.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) fenpropidin. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) fenpropimorf.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) fenpropidin. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) fenpropimorf.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbornene-5-yl)amide and as component (B) bixafen. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, which comprises as component (A) the compound 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and as component (B) bixafen. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) ciprodinil.
A composition according to claim 1, wherein component (A) is 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylidene-benzonorbomene-5-yl)amide and component (B) is selected from azoxystrobin and picoxystrobin. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1 H-pirazol-4-karboksilna kiselina (9-diklorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) fenpropimorf.
A composition according to claim 1, wherein component (A) is 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-difluoromethylidene-benzonorbornene-5-yl)amide and component (B) is selected from azoxystrobin and picoxystrobin. 
Pripravak prema zahtjevu 1, naznačen time da kao komponentu (A) sadrži spoj 3-difluorometil-1-metil-1H-pirazol-4-karboksilna kiselina (9-difluorometiliden-benzonorbornen-5-il)amid, te kao komponentu (B) fenpropimorf.
A sander according to claim 3 or 4 caracterizd in that the pin (21) is in its axis fitted with a locking screw (22) to affix the position of the pull-bar (19) to this pin. 
Brusni alat prema Zahtjevu 3 ili 4, naznačeno time da vijak (21) je u svojoj osi spojen sa vijkom za osiguranje (22) da bi se fiksirao položaj potezne šipke (19) u ovom vijku.
A sander according to claim 1 or 2, characterized in that the flexible pressure plate (1) of the sander is fitted with mechanical drive actuator embodying a bottom surface of the pressure plate fitted with at least one movable profiled plate (27) with mechanical drive moving linearly between the pressure plate and the sanded surface, where the bottom surface of the movable profiled plate is fitted with a known system for affixing the sanding tool, mainly sanding paper or cloth or even abrasive material. 
Brusni alat prema Zahtjevu 1 ili 2, naznačeno time da je fleksibilna potisna ploča (1) brusnog alata opremljena mehaničkim pogonom koji je sjedinjen sa donjom površinom potisne ploče koja ima najmanje jednu pokretnu profiliranu ploču (27) koja se mehanički pomiče linearno između potisne ploče i površine koja se brusi, gdje je donja površina pokretne profilirane ploče opremljena sa poznatim sistemom za pričvršćivanje brusnog materijala, uglavnom brusnog papira ili brusnog platna ili abrazivnog materijala.
A sander according to claim 2, characterized in that at least one flexible pressure plate (1) is movable in opposite direction in the same axis as the other pressure plate(s) (1). 
Brusni alat prema Zahtjevu 2, naznačeno time da je najmanje jedna fleksibilna potisna ploča (1) pokretna u suprotnom smjeru u istoj osi kao druga potisna ploča (ploče) (1).
A sander according to any of the claims 1 to 9, characterized in that it comprises at least two or more interconnected pressure plates (1) and at least two or more sanding belts with adjustable speed, where these belts move in reciprocally opposite direction. 
Brusni alat prema bilo kojem Zahtjevu od 1 do 9, naznačeno time da se sastoji od najmanje dvije ili više međusobno povezanih potisnih ploča (1) i najmanje dva ili više brusnih traka sa podesivom brzinom, gdje se ove trake kreću u uzajamno suprotnim pravcima.
Method according to claims 11 or 12, characterized in that the pressure plate (1) presses the sanding tool (paper, cloth or other carrier of abrasive layer) to a sanded surface (14) in all the length of the sanding tool applying approximately constant pressure, which is evenly applied on the entire line of the sanding surface. 
Način prema Zahtjevima 11 ili 12, naznačeno time da potisna ploča (1) pritišće brusni materijal (papir, platno ili drugi nosač abrazivnog materijala) na površinu koja se brusi (14) po cijeloj dužini brusnog alata primjenjujući približno stalni pritisak, koji je ravnomjerno raspoređen po cijeloj površini koja se brusi.
Method according to any of claims 11 to 15 characterized in that abrasion dust suction is also ensured by that a flexible cover plate is pressed through a sealing rubber to a top part of another flexible pressure plate where between these two plates there exists an enclosure where the cover plate is not connected to the pressure plate in any solid way thus having on vital effect on the flexibility of the pressure plate. 
Način prema bilo kojem Zahtjevu od 11 do 15 naznačeno time da odsisavanje brusne prašine je osigurano tako da je fleksibilna pokrovna ploča pritisnuta gumenom brtvom na gornjem dijelu druge fleksibilne potisne ploče gdje između ovih dviju ploča postoji zatvoren prostor gdje potisna ploča nije povezana sa potisnom pločom na bilo koji kruti način i tako se ostvaruje bitan učinak fleksibilnosti potisne ploče.
A compound or salt thereof, wherein: 
Spoj ili njegova sol, naznačen time, da:
the compound corresponds in structure to formula I-L0: is selected from the group consisting of single carbon-carbon bond and double carbon-carbon bond; 
spoj odgovara strukturi formule I-L0: [image] [image] je odabran iz skupine koja se sastoji od jednostruke veze ugljik-ugljik i dvostruke veze ugljik-ugljik;
is selected from the group consisting of hydrogen and methyl; 
je odabran iz skupine koja sadrži vodik i metil;
is selected from the group consisting of hydrogen, halo, hydroxy, methyl, cyclopropyl, and cyclobutyl; 
je odabran iz skupine koja sadrži vodik, halo, hidroksi, metil, ciklopropil i ciklobutil;
is selected from the group consisting of hydrogen, halo, oxo, and methyl; 
je odabran iz skupine koja sadrži vodik, halo, okso i metil;
the amino, aminocarbonyl, and aminosulfonyl optionally are substituted with: 
amino, aminokarbonil i aminosulfonil su po izboru supstituirani s:
two substituents that, together with the amino nitrogen, form a single-ring heterocyclyl, and 
dva supstituenata koja, zajedno s amino dušikom, tvore jednostruki heterociklilni prsten, i
the alkyl, alkenyl, alkynyl, alkyloxy, alkenyloxy, alkynyloxy, and alkylsulfonyl, optionally are substituted with one or more substituents independently selected from the group consisting of halo, oxo, nitro, cyano, azido, hydroxy, amino, alkyloxy, trimethylsilyl, carbocyclyl, and heterocyclyl, wherein: the amino optionally is substituted with: 
alkil, alkenil, alkinil, alkiloksi, alkeniloksi, alkiniloksi i alkilsulfonil, po izboru su supstituirani jednim ili više supstituenata neovisno odabranima iz skupine koja sadrži halo, okso, nitro, cijano, azido, hidroksi, amino, alkiloksi, trimetilsilil, karbociklil i heterociklil, gdje: amino je po izboru supstituiran s:
two substituents that, together with the amino nitrogen, form a single-ring heterocyclyl, and 
dva supstituenata koji, zajedno s amino dušikom, tvore jednostruki heterociklilni prsten, i
the carbocyclyl and heterocyclyl optionally are substituted with up to three substituents independently selected from the group consisting of alkyl, alkenyl, alkynyl, halo, oxo, nitro, cyano, azido, hydroxy, amino, alkyloxy, trimethylsilyl, carbocyclyl, and heterocyclyl, wherein: the amino optionally is substituted with: 
karbociklil i heterociklil po izboru su supstituirani jednim do tri supstituenta neovisno odabranima iz skupine koja sadrži alkil, alkenil, alkinil, halo, okso, nitro, cijano, azido, hidroksi, amino, alkiloksi, trimetilsilil, karbociklil i heterociklil, gdje: amino je po izboru supstituiran s:
two substituents that, together with the amino nitrogen, form a single-ring heterocyclyl; 
dva supstituenta koji, zajedno s amino dušikom, tvore jednostruki heterociklilni prsten;